Outcome of second malignancies after retinoblastoma: A retrospective analysis of 25 patients treated at the Institut Curie

European Journal of Cancer

Volumn 40, Issue 10, 2004, Pages 1522-1529

  Aerts, Isabelle ^a   Pacquement, Hélène ^a   Doz, François ^a   Mosseri, Véronique ^a   Desjardins, Laurence ^a   Sastre, Xavier ^a   Michon, Jean ^a   Rodriguez, José ^a   Schlienger, Pierre ^a   Zucker, Jean Michel ^a   Quintana, Erica ^a  

^a INSTITUT CURIE   (France)

Author keywords

Antineoplastic agent; Retinoblastoma; Second primary neoplasm; Surgery; Survival

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; BEAM THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL FEATURE; ENUCLEATION; HISTOPATHOLOGY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; OLIGODENDROGLIOMA; OSTEOSARCOMA; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RADIATION FIELD; RETINOBLASTOMA; RETROSPECTIVE STUDY; SOFT TISSUE SARCOMA; TREATMENT OUTCOME;

CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS, SECOND PRIMARY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROGNOSIS; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 2942605981     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.03.023     Document Type: Article

References (30)

1. Donaldson S., Egbert P.R., Newsham I., Cavenee W.K. Retinoblastoma. Pizzo P.A., Poplack D.G. Principles and practice of pediatric oncology. 3rd ed. 1997;699-716 JB Lippincott, Philadelphia
2. Eng C.E., Li F.P., et al. Mortality for second tumors among long-term survivors of retinoblastoma. J. Natl. Cancer Inst. 85:1993;1121-1128
3. Mohney B.G., Robertson D.M., Schomberg P.J., Hodge D.O. Second non ocular tumors in survivors of heritable retinoblastoma and prior radiotherapy. Am. J. Ophthalmol. 126:1998;269-277
4. Smith L.M., Donaldson S.S., Egbert P.R., Link M.P., Bagshaw M.A. Aggressive management of second malignant neoplasms in survivors of hereditary retinoblastoma. Int. J. Radiat. Oncol. Biol. Phys. 17:1989;499-505
5. Moll A.C., Imhof S.M., Bouter L.X., et al. Second malignant neoplasms in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994. Int. J. Cancer. 67:1996;515-519
6. Desjardins L., Haye C., Schlienger P., Laurent M., Zucker J.M., Bouguila H. Second non ocular tumors in survivors of bilateral retinoblastoma a 30-year follow-up. Ophthalmic Pediatr. Genet. 12:1991;145-148
7. Fontanesi J., Parham D.M., Pratt C., Meyer D. Second malignant neoplasms in children with retinoblastoma: the St Jude Children's research Hospital experience. Ophthalmic Genet. 16:1996;105-108
8. Moll A.C., Imhof S.M., Bouter L.X., Tan K.E.W. Second malignant neoplasms in patients with retinoblastoma A review of the literature. Ophthalmic Genet. 18:1997;27-34
9. Abramson D.H., Ellsworth R.M., Kitchin F.D., Tung G. Second non ocular tumors in retinoblastoma survivors. Are they radiation - induced ? Ophthalmology. 91:1984;1351-1355
10. Abramson D.H. Second nonocular cancers in retinoblastoma: a unified hypothesis. The Franceschetti Lecture. Ophtalmic genet. 20:1999;193-204
11. Friend S.H., Bernards R., Rogelj S., et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323:1986;643-646
12. Wong L.F.L., Boice J.D., Abramson D.H., et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA. 278:1997;1262-1267
13. Dunkel I.J., Gerald W.L., Rosenfield N.S., Strong E.W., Abramson D.H., Ghavimi F. Outcome of patients with a history of bilateral retinoblastoma treated fo a second malignancy: the Memorial Sloan-Kettering experience. Med. Pediatr. Oncol. 30:1998;59-62
14. Hawkins M.M., Wilson L.M., Burton H.S., et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J. Natl. Cancer Inst. 88:1996;270-278
15. Moll A.C., Imhof S.M., Schouten-Van Meeteren A.Y., Kuik D.J., Hofman P., Boers M. Second malignant neoplasms in hereditary retinoblastoma: a register-based study, 1945-1997: is there an age effect on radiation-related risk. Ophthalmology. 108:2001;1109-1114
16. Le Vu B., De Vathaire F., Shamsaldin A., et al. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumors during childhood. Int. J. Cancer. 77:1998;370-377
17. Newton W.A., Meadows A.T., Shimada H., Bunin G.R., Vawter G.F. Bone sarcomas as second malignant neoplasms following childhood cancer. Cancer. 67:1991;193-201
18. Hasegawa T., Matsuro Y., Niki T., et al. Second primary rhabdomyosarcomas in patients with bilateral retinoblastoma: a clinicopathologic and immunohistochemical study. Am. J. Surg. Pathol. 22:1998;1351-1360
19. Traboulsi E.I., Zimmerman L.E., Manz H.J. Cutaneous malignant melanoma in survivors of heritable retinoblastoma. Arch. Ophthalmol. 106:1988;1059-1061
20. Paulino A.C. Trilateral retinoblastoma: is the location of the intracranial tumor important. Cancer. 86:1999;135-141
21. Cahan W., Wooddard H., Higinbotham N., Srewart F., Coley B. Sarcoma arising in irradiated bone: report of eleven cases. Cancer. 1:1948;3-29
22. Shields C.L., Shields J.A., De Potter P., et al. Plaque radiotherapy in the management of retinoblastoma. Use as a primary or secondary treatment. Ophthalmology. 100:1993;216-224
23. Khelfaoui F., Validire P., Auperin A., et al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer. 77:1996;1206-1213
24. Miser J.S., Kinsella T.J., Triche T.J., et al. Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of reccurent sarcomas and other tumors of children and young adults. J. Clin. Oncol. 5:1987;1191-1198
25. Philip T, Iliescu C, Demaille MC, et al. High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]-doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Société Française d'Oncologie Pédiatrique. Ann Oncol 1999;10(9):1065-71
26. Pendergrass T.W., Milstein J.M., Geyer J.R., et al. Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. J. Clin. Oncol. 5:1987;1221-1231
27. Huvos A.G., Rosen G., Marcove R.C. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy, in bloc resection and prosthetic bone replacement. Arch. Pathol. Lab. Med. 101:1977;14-18
28. Dickman P.S., Barmada M., Gollin S.M., Blatt J. Malignancy after retinoblastoma: secondary cancer or recurrence. Hum. Pathol. 28:1997;200-205
29. Lumbroso L., Doz F., Urbieta M., et al. Chemothermotherapy in the management of retinoblastoma. Ophtalmology. 109:2002;1130-1136
30. Chauveinc L., Mosseri V., Quintana E., et al. Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet. 22:2001;77-88